NASDAQ : XNCR

Xencor, Inc. — Financial statements

Healthcare · Biotechnology · United States

Last price 29.82 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.22B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Xencor, Inc. (XNCR) reported revenue of 104.97M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue104.97M125.58M110.49M174.62M164.58M275.11M
Cost of Revenue255.76M239.43M227.69M253.60M199.56M192.51M
Gross Profit-150.79M-113.86M-117.19M-78.98M-34.98M82.60M
Selling, General & Admin65.28M63.64M58.89M52.11M47.49M38.84M
Operating Expenses65.28M63.64M58.89M52.11M47.49M38.84M
Operating Income-216.08M-177.50M-176.08M-131.09M-82.47M43.77M
Interest Expense-27.07M-31.93M-36.64M-6.18M-13.00K-13.00K
Interest & Investment Income23.00M27.52M31.93M19.33M4.83M862.00K
Other Non Operating Income (Expenses)805.00K-73.00K50.00K-31.00K-148.00K-1.27M
EBT Excluding Unusual Items-219.35M-181.98M-180.74M-117.97M-77.80M43.34M
Gain (Loss) on Sale of Investments61.74M101.51M-51.85M-395.00K23.30M39.29M
Asset Writedown-3.24M-9.17M-2.33M-1.27M
Pretax Income-160.85M-89.63M-234.92M-119.63M-54.51M82.63M
Income Tax Expense2.48M2.50M1.62M13.66M673.00K
Earnings From Continuing Operations-163.32M-92.14M-236.54M-133.30M-55.18M82.63M
Minority Interest in Earnings214.00K3.92M163.00K
Net Income-163.32M-91.92M-232.62M-133.13M-55.18M82.63M
Net Income to Common-163.32M-91.92M-232.62M-133.13M-55.18M82.63M
Shares Outstanding (Basic)75.03M74.24M65.04M60.50M59.65M58.38M
Shares Outstanding (Diluted)75.03M74.24M65.04M60.50M59.65M60.50M
EPS (Basic)-2.18-1.24-3.58-2.20-0.931.42
EPS (Diluted)-2.18-1.24-3.58-2.20-0.931.37
Free Cash Flow-208.28M-138.27M-208.28M-96.37M-14.01M-30.15M
Free Cash Flow Per Share-2.78-1.86-3.20-1.59-0.23-0.50
Gross Margin-143.65%-90.67%-106.06%-45.23%-21.26%30.03%
Operating Margin-205.84%-141.35%-159.36%-75.08%-50.11%15.91%
Profit Margin-155.59%-73.20%-210.53%-76.24%-33.53%30.04%
Free Cash Flow Margin-198.42%-110.11%-188.50%-55.19%-8.51%-10.96%
EBITDA-205.90M-166.99M-163.97M-119.60M-73.67M51.26M
EBITDA Margin-196.15%-132.98%-148.40%-68.49%-44.77%18.63%
D&A For EBITDA10.17M10.51M12.11M11.50M8.80M7.49M
EBIT-216.08M-177.50M-176.08M-131.09M-82.47M43.77M
EBIT Margin-205.84%-141.35%-159.36%-75.08%-50.11%15.91%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents44.66M54.07M40.88M53.79M53.94M143.48M
Short-Term Investments411.79M493.66M456.90M539.93M569.12M190.63M
Cash & Short-Term Investments456.45M547.73M497.77M593.73M623.06M334.11M
Accounts Receivable42.23M29.30M60.85M23.74M29.00M66.38M
Receivables42.23M29.30M60.85M23.74M29.00M66.38M
Prepaid Expenses24.53M22.79M18.98M18.14M23.28M23.88M
Total Current Assets523.21M599.82M577.60M635.60M675.34M424.37M
Property, Plant & Equipment86.00M90.90M98.14M100.12M93.60M59.97M
Long-Term Investments108.53M175.60M256.83M209.72M58.21M331.73M
Other Intangible Assets6.52M8.38M18.48M18.66M18.50M16.49M
Other Long-Term Assets689.00K787.00K885.00K1.03M613.00K653.00K
Total Assets724.96M875.50M951.95M965.13M846.27M838.21M
Accounts Payable12.65M10.83M16.76M13.91M10.09M14.00M
Accrued Expenses36.45M34.96M19.22M23.56M18.73M19.44M
Current Portion of Long-Term Debt27.36M43.27M48.45M27.71M
Current Portion of Leases3.92M3.26M3.01M3.44M4.71M
Current Income Taxes Payable1.50M3.59M5.29M
Current Unearned Revenue30.32M37.29M
Total Current Liabilities81.86M95.91M87.43M73.92M63.84M70.74M
Long-Term Debt77.54M76.48M115.16M161.77M
Long-Term Leases61.30M64.73M65.34M59.02M54.93M33.97M
Other Long-Term Liabilities1.03M2.78M9.99M8.34M
Total Liabilities221.73M239.91M277.92M303.05M118.77M104.71M
Common Stock744.00K718.00K703.00K611.00K601.00K595.00K
Additional Paid-In Capital1.45B1.43B1.38B1.13B1.07B1.02B
Retained Earnings-946.60M-795.96M-704.04M-471.42M-338.29M-283.10M
Comprehensive Income & Other-872.00K1.58M-663.00K1.29M-6.95M-1.51M
Total Common Equity503.23M635.59M677.61M661.75M727.50M733.50M
Minority Interest-3.58M337.00K
Shareholders' Equity503.23M635.59M674.03M662.09M727.50M733.50M
Total Liabilities & Equity724.96M875.50M951.95M965.13M846.27M838.21M
Total Debt170.11M187.75M231.95M251.94M59.63M33.97M
Net Cash (Debt)394.88M535.59M522.65M551.50M621.64M631.87M
Net Cash Per Share5.267.218.049.1210.4210.44
Filing Date Shares Outstanding74.35M73.34M70.46M61.12M60.03M59.38M
Total Common Shares Outstanding74.33M71.87M70.26M61.00M60.00M59.36M
Working Capital441.35M503.91M490.17M561.69M611.50M353.63M
Book Value Per Share6.778.849.6410.8512.1312.36
Tangible Book Value496.70M627.20M659.13M643.09M709.00M717.01M
Tangible Book Value Per Share6.688.739.3810.5411.8212.08
Machinery46.15M45.88M43.20M49.94M45.70M42.49M
Construction In Progress7.17M6.63M7.22M
Leasehold Improvements52.49M52.27M51.57M52.41M41.77M8.57M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-163.32M-91.92M-232.62M-133.13M-55.18M82.63M
Depreciation & Amortization10.17M10.51M12.11M11.50M8.80M7.49M
Loss (Gain) From Sale of Assets1.58M1.38M145.00K462.00K
Asset Writedown & Restructuring Costs3.24M9.17M2.33M1.27M1.51M934.00K
Loss (Gain) From Sale of Investments-63.87M-105.00M35.77M-13.24M-23.17M-17.07M
Stock-Based Compensation39.03M43.23M53.28M53.76M48.91M36.98M
Other Operating Activities-33.57M-48.56M-34.23M-18.59M-5.40M-25.68M
Change in Accounts Receivable-8.54M28.73M-32.67M19.83M37.39M-42.44M
Change in Accounts Payable-6.13M-3.95M2.85M3.83M-3.91M5.05M
Change in Unearned Revenue-30.32M-6.97M-55.32M
Change in Income Taxes3.59M3.59M-4.48M13.63M
Change in Other Net Operating Assets13.58M19.08M-6.09M12.16M22.36M-9.89M
Operating Cash Flow-205.81M-135.12M-202.19M-77.93M24.48M-16.85M
Capital Expenditures-2.47M-3.15M-6.10M-18.45M-38.49M-13.30M
Sale of Property, Plant & Equipment1.00K19.00K
Sale (Purchase) of Intangibles-3.42M-2.80M-4.91M-2.68M
Investment in Securities200.11M143.13M1.64M-89.81M-81.32M-24.45M
Other Investing Activities5.00M-5.84M
Investing Cash Flow197.64M139.99M-7.87M-111.06M-119.72M-46.25M
Issuance of Common Stock8.30M9.96M209.23M5.39M5.70M43.04M
Other Financing Activities-1.73M-12.08M183.83M
Financing Cash Flow8.30M8.23M197.15M189.22M5.70M43.04M
Net Cash Flow126.00K13.10M-12.91M228.00K-89.54M-20.06M
Free Cash Flow-208.28M-138.27M-208.28M-96.37M-14.01M-30.15M
Free Cash Flow Margin-198.42%-110.11%-188.50%-55.19%-8.51%-10.96%
Free Cash Flow Per Share-2.78-1.86-3.20-1.59-0.23-0.50
Levered Free Cash Flow-94.54M-39.17M-121.82M-47.76M-10.87M-48.19M
Unlevered Free Cash Flow-77.62M-19.21M-98.91M-43.90M-10.86M-48.19M
Cash Interest Paid8.00K5.00K33.00K22.00K13.00K14.00K
Cash Income Tax Paid4.45M7.31M6.10M700.00K
Change in Working Capital2.50M47.45M-40.40M19.13M48.87M-102.60M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization2.21B1.09B1.61B1.29B1.56B2.35B
Enterprise Value1.81B577.50M858.59M773.98M930.43M1.82B
Last Close Price29.6615.3122.9821.2326.0440.12
PE Ratio28.39
PS Ratio21.018.7114.557.409.488.53
PB Ratio4.381.722.391.952.153.20
P/TBV Ratio4.441.742.442.012.203.27
P/OCF Ratio63.73
EV/Sales Ratio17.254.607.774.435.656.60
EV/EBITDA Ratio35.42
EV/EBIT Ratio41.48
Debt / Equity Ratio0.340.290.340.380.080.05
Debt / EBITDA Ratio0.61
Net Debt / Equity Ratio-0.79-0.84-0.78-0.83-0.85-0.86
Net Debt / EBITDA Ratio1.923.213.194.618.44-12.33
Net Debt / FCF Ratio1.903.872.515.7244.3720.96
Asset Turnover0.130.140.120.190.200.36
Quick Ratio6.096.026.398.3510.215.66
Current Ratio6.396.256.618.6010.586.00
Return on Equity (ROE)-29.07%-14.07%-35.41%-19.18%-7.55%12.65%
Return on Assets (ROA)-16.84%-12.14%-11.48%-9.05%-6.12%3.55%
Return on Invested Capital (ROIC)-93.39%-51.92%-48.34%-54.13%-27.61%10.10%
Return on Capital Employed (ROCE)-33.60%-22.80%-20.40%-14.70%-10.50%5.70%
Earnings Yield-7.34%-8.41%-14.46%-10.30%-3.54%3.52%
FCF Yield-9.44%-12.65%-12.95%-7.46%-0.90%-1.29%
Buyback Yield / Dilution-5.22%-14.14%-7.50%-1.43%1.39%-5.74%